Cargando…
An Intranasal Vaccine Based on Outer Membrane Vesicles Against SARS-CoV-2
The prevailing pandemic of SARS-CoV-2 highlights the desperate need of alternative vaccine-platforms, which are safe, effective, and can be modified to carry antigens of emerging pathogens. The current SARS-CoV-2 vaccines based on mRNA and adenoviral vector technology meet some of these criteria but...
Autores principales: | Thapa, Himadri B., Müller, Anna M., Camilli, Andrew, Schild, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602898/ https://www.ncbi.nlm.nih.gov/pubmed/34803974 http://dx.doi.org/10.3389/fmicb.2021.752739 |
Ejemplares similares
-
Outer membrane vesicles as versatile tools for therapeutic approaches
por: Zingl, Franz G, et al.
Publicado: (2021) -
Bacterial outer membrane vesicle biogenesis: a new mechanism and its
implications
por: Roier, Sandro, et al.
Publicado: (2016) -
Outer Membrane Vesicles of Vibrio cholerae Protect and Deliver Active Cholera Toxin to Host Cells via Porin-Dependent Uptake
por: Zingl, Franz G., et al.
Publicado: (2021) -
Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice
por: Roier, Sandro, et al.
Publicado: (2012) -
Correction: Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice
por: Roier, Sandro, et al.
Publicado: (2012)